Collegium Pharmaceutical, Inc. (COLL)

49.56 +0.71 (+1.45%) USD  |  NASDAQ  |  Dec 24, 12:59
49.56 0.00 (0.00%) After-Hours: 13:59
More

Collegium Pharmaceutical Return on Invested Capital (3y Median)

Return on Invested Capital (3y Median) Chart

View Return on Invested Capital (3y Median) for COLL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Invested Capital (3y Median) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Invested Capital (3y Median) Range, Past 5 Years

View Return on Invested Capital (3y Median) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Invested Capital (3y Median) Benchmarks

View Return on Invested Capital (3y Median) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Altimmune, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade